Accelerated approval may not be appropriate for early coronavirus vaccine candidates, CBER Director Peter Marks said in an up-close look at FDA’s decision-making as it developed its guidance. • Source: screenshot
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
